FDA Inspection
Isomedix Operations, Inc.Isomedix Operations, Inc. – FDA Inspection, Oct 29, 2018
Record Details
This FDA Inspection record concerns Isomedix Operations, Inc., with an inspection on October 29, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Yvesna C. Blaise (Issuing Officer)
View Company Profile
ID · 1c234f9e-6beb-4a20-9851-f6c2f47ab76c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1070676
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Isomedix Operations, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 1, 2022 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| March 13, 2017 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| February 12, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Isomedix Operations, Inc.
- FDA Inspection 1270535 - 2025-05-08
- FDA Inspection 1249207 - 2024-08-29
- FDA Inspection 1191036 - 2022-11-01
- FDA Inspection 1008522 - 2017-03-13
- FDA Inspection 916347 - 2015-02-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.